Krischer, Jeffrey P.

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Skyler, J. S., Beam, C. A., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Matheson, D., Herold, K. C., Palmer, J. P., et al. (2013) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 85

Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial-Type 1

Sosenko, J. M., Palmer, J. P., Rafkin-Mervis, L., Krischer, J. P., Cuthbertson, D., Mahon, J., Greenbaum, C. J., Cowie, C. C., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2009) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 76

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 Participants

Sosenko, J. M., Palmer, J. P., Rafkin, L. E., Krischer, J. P., Cuthbertson, D., Greenbaum, C. J., Eisenbarth, G., Skyler, J. S., & Diabetes Prevention Trial–Type 1 Study Group (2010) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 62

Residual beta-cell function in diabetes children followed and diagnosed in the TEDDY study compared to community controls: STECK et al .

Steck, A. K., Larsson, H. E., Liu, X., Veijola, R., Toppari, J., Hagopian, W. A., Haller, M. J., Ahmed, S., Akolkar, B., Lernmark, Å., et al. (2017) · Pediatric Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 56

Predicting progression to type 1 diabetes from ages 3 to 6 in islet autoantibody positive TEDDY children

Jacobsen, L. M., Larsson, H. E., Tamura, R. N., Vehik, K., Clasen, J., Sosenko, J., Hagopian, W. A., She, J., Steck, A. K., Rewers, M., et al. (2019) · Pediatric Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 48

The Application of the Diabetes Prevention Trial–Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes

Sosenko, J. M., Skyler, J. S., Mahon, J., Krischer, J. P., Beam, C. A., Boulware, D. C., Greenbaum, C. J., Rafkin, L. E., Cowie, C., Cuthbertson, D., et al. (2012) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 44

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 (DPT-1)

Sosenko, J. M., Skyler, J. S., Krischer, J. P., Greenbaum, C. J., Mahon, J., Rafkin, L. E., Cuthbertson, D., Cowie, C., Herold, K., Eisenbarth, G., et al. (2010) · Diabetes

Diabetes and associated disordersDiabetes Management and Research

Cited by 38

GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus

Schoot, M., Schatz, D., Atkinson, M., Krischer, J., Mehta, H., Vold, B., & Maclaren, N. (1994) · Journal of Autoimmunity

Diabetes and associated disordersDiabetes Management and Research

Cited by 34